STD Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments and Devices, Consumables, and Software); By Application; Technology; By Region; Segment Forecast, 2024 - 2032

STD Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments and Devices, Consumables, and Software); By Application; Technology; By Region; Segment Forecast, 2024 - 2032

The global STD diagnostics market size is expected to reach USD 19.63 billion by 2032, according to a new study by Polaris Market Research. The report “STD Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments and Devices, Consumables, and Software); By Application; By Technology; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising number of government initiatives promoting the development or creation of technologically advanced diagnostic solutions providing precise testing and increased public awareness as well as patient education, are the key factors projected to drive market’s growth. Increasing healthcare expenditure or spending from both government and private organizations resulting in greater access to improved healthcare facilities and diagnostics for various diseases including STDs.

For instance, in November 2023, Daye, announced the launch of an STI diagnostic tampon, that uses a PCR (polymerase chain reaction) test to check several infections including chlamydia, gonorrhoea, ureaplasma, and trichomonas. The solution is designed to speed up the diagnosis and treatment of STIs.

Furthermore, the rapid emergence of CRISPR-based diagnostics as cutting-edge technology offering sensitive and specific detection of nucleic acids is gaining traction. CRISPR-Cas systems for the detection of nucleic acids appear to be extremely sensitive and capable on one-step detection of both DNA and RNA. Thereby, these tests are gaining huge popularity due to their potential to enhance the overall accuracy of STD diagnostics and becoming a highly valuable tool for point-of-care testing.

The rapid development of at-home STD testing kits that provide individuals greater convenient and options for self-testing, is also increasing the accessibility of these devices. Thereby, people with privacy concerns and growing interest in self-testing of their STDs among people worldwide, have the potential for the expansion and development of at-home testing solutions. For instance, in October 2023, Lindus Health and Daye, announced that they have teamed up for the launch of a clinical trail that investigates a capability of tampon for the detection of STIs and HPV. The newly developed tampon likely to prove a more accessible at-home alternative with greater efficacy and safety.

STD Diagnostics Market Report Highlights

Consumables segment accounted for noteworthy share, on account of its significant adoption worldwide due to ability to provide accurate and reliable results

HIV testing segment held the majority share, that is attributed to rising incidences of HIV diseases and advancements in testing capabilities

Molecular diagnostics segment will grow at highest pace, due to growing use of high-throughput PCR technology and adoption of at-home molecular testing

North America dominated the global market, owing to rising prevalence of STIs and robust presence of well-established and developed healthcare infrastructure

The key market players include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Roche Diagnostics, Thermo Fisher Scientific, Quidel Corporation, and QIAGEN

Polaris Market Research has segmented the STD diagnostics market report based on product, application, technology, and region:

STD Diagnostics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Instruments and Devices

Consumables

Software

STD Diagnostics, Application Outlook (Revenue - USD Billion, 2019 - 2032)

CT/NG Testing

Syphilis Testing

Gonorrhea Testing

HSV Testing

HPV Testing

HIV Testing

Ureaplasma & Mycoplasma

Trichomonas

VZV Testing

Others

STD Diagnostics, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

Immunoassay

Molecular Diagnostics

Others

STD Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa